Remote Jobs at Actithera

Actithera

1 - 10 employees

🧬 Biotechnology

💊 Pharmaceuticals

🔥 Funding within the last year

💰 $75.5M Series A - Actithera on 2025-07

Biotechnology • Pharmaceuticals

Actithera is a biotechnology company developing next-generation radioligand therapies (RLTs) for cancer. The company designs molecules that link radioactive isotopes to small molecules and modified peptides to deliver targeted, sustained radiation to tumors while sparing healthy tissues. Actithera is a discovery-stage firm with assets in IND-enabling studies and aims to enable effective, better-tolerated, personalized cancer treatments with fewer therapy cycles through proprietary chemistry that matches radionuclide half-lives to tumor residence time.